|
Szulkin R, Whitington T, Eklund M, Aly M, Eeles RA, Easton D, et al. |
Prediction of individual genetic risk to prostate cancer using a polygenic ... |
Friday, July 17, 2015 |
The Prostate |
|
Cortes-Ciriano I, Murrell DS, van Westen GJ, Bender A, Malliavin TE |
Prediction of the potency of mammalian cyclooxygenase inhibitors with ensem... |
Tuesday, February 24, 2015 |
Journal of cheminformatics |
|
Giger OT, Ten Hoopen R, Shorthouse D, Abdullahi S, Bulusu VR, Jadhav S, Mah... |
Preferential MGMT hypermethylation in SDH-deficient wild-type GIST |
Wednesday, October 5, 2022 |
J Clin Pathol |
|
Eggermann T, Brioude F, Russo S, Lombardi MP, Bliek J, Maher ER, et al. |
Prenatal molecular testing for Beckwith-Wiedemann and Silver-Russell syndro... |
Thursday, October 29, 2015 |
European journal of human genetics : EJHG |
|
Andrews LJ, Thornton ZA, Saincher SS, Yao IY, Dawson S, McGuinness LA, Jone... |
Prevalence of BRAFV600 in glioma and use of BRAF Inhibitors in patients wit... |
Thursday, October 28, 2021 |
Neuro Oncol |
|
Kote-Jarai Z, Mikropoulos C, Leongamornlert DA, Dadaev T, Tymrakiewicz M, S... |
Prevalence of the HOXB13 G84E germline mutation in British men and correlat... |
Sunday, January 18, 2015 |
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO |
|
Taj MM, Maecker-Kolhoff B, Ling R, Bomken S, Burkhardt B, Chiang AKS, Csoka... |
Primary post-transplant lymphoproliferative disorder of the central nervous... |
Thursday, March 25, 2021 |
Br J Haematol |
|
Gnanapragasam VJ, Payne H, Syndikus I, Kynaston H, Johnstone T |
Primary radical therapy selection in high-risk non-metastatic prostate canc... |
Wednesday, December 3, 2014 |
Clinical oncology (Royal College of Radiologists (Great Britain)) |
|
Barry PA, Schiavon G |
Primary Systemic Treatment in the Management of Operable Breast Cancer: Bes... |
Saturday, June 13, 2015 |
Journal of the National Cancer Institute Monographs |
|
Fiona M. Behan, Francesco Iorio, Gabriele Picco, Emanuel Gonçalves, Charlo... |
Prioritization of cancer therapeutic targets using CRISPR–Cas9 screens |
Wednesday, April 10, 2019 |
Nature |
